Literature DB >> 22588496

Histological examination and evaluation of donor bile ducts received during orthotopic liver transplantation--a morphological clue to ischemic-type biliary lesion?

Torsten Hansen1, David Hollemann, Michael B Pitton, Michael Heise, Maria Hoppe-Lotichius, Marcus Schuchmann, C James Kirkpatrick, Gerd Otto.   

Abstract

Ischemic-type biliary lesions (ITBL) belong to a group of biliary disorders that are regarded as the major complication in patients with orthotopic liver transplantation (OLT). We performed histological evaluation of donor common bile ducts received during OLT to find morphological clues to the pathomechanisms of ITBL. We investigated 93 grafts of 92 patients (recipients: mean age, 56.5 years; underlying disease: hepatocellular carcinoma (n = 45), alcoholic cirrhosis (n = 16), viral hepatitis with cirrhosis (n = 9), retransplantations (n = 9), others (n = 14); donors: mean age, 53.2 years). Donor common bile ducts were received after recirculation of the hepatic artery prior to biliary end-to-end anastomosis and routinely processed. Statistical evaluation was performed by chi-square analysis and multivariate analysis using a logistic regression model. With regard to ITBL (observed in 19.4 %), the following phenomena were found to be statistically relevant: necrosis of the bile duct wall, arteriolonecrosis, vascular lesions (such as subintimal edema), and intramural bleeding (P < 0.001, P < 0.001, P = 0.029, and P = 0.031, respectively). In logistic regression analysis, arteriolonecrosis was the only parameter with significance (P = 0.001). Based on these results on the morphology of the donor common bile duct, we conclude that these phenomena of vascular damage, reflecting microangiopathy, play a major role in the pathogenesis of ITBL.

Entities:  

Mesh:

Year:  2012        PMID: 22588496     DOI: 10.1007/s00428-012-1245-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

1.  Diffuse biliary tract injury after orthotopic liver transplantation.

Authors:  S Li; R J Stratta; A N Langnas; R P Wood; W Marujo; B W Shaw
Journal:  Am J Surg       Date:  1992-11       Impact factor: 2.565

2.  Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.

Authors:  J Pirenne; F Van Gelder; W Coosemans; R Aerts; B Gunson; T Koshiba; I Fourneau; D Mirza; W Van Steenbergen; J Fevery; F Nevens; P McMaster
Journal:  Liver Transpl       Date:  2001-06       Impact factor: 5.799

Review 3.  Innate alloimmunity: history and current knowledge.

Authors:  Walter Land
Journal:  Exp Clin Transplant       Date:  2007-06       Impact factor: 0.945

Review 4.  Protection of bile ducts in liver transplantation: looking beyond ischemia.

Authors:  Sanna Op den Dries; Michael E Sutton; Ton Lisman; Robert J Porte
Journal:  Transplantation       Date:  2011-08-27       Impact factor: 4.939

5.  Biliary complications after prolonged University of Wisconsin preservation of liver allografts.

Authors:  M Kadmon; J Bleyl; B Küppers; G Otto; C Herfarth
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

Review 6.  Biliary complications after liver transplantation: a review.

Authors:  Robert C Verdonk; Carlijn I Buis; Robert J Porte; Elizabeth B Haagsma
Journal:  Scand J Gastroenterol Suppl       Date:  2006

7.  Endoscopic management of biliary complications after orthotopic liver transplantation.

Authors:  R E Hintze; A Adler; W Veltzke; H Abou-Rebyeh; R Felix; P Neuhaus
Journal:  Hepatogastroenterology       Date:  1997 Jan-Feb

Review 8.  Causes and consequences of ischemic-type biliary lesions after liver transplantation.

Authors:  Carlijn I Buis; Harm Hoekstra; Robert C Verdonk; Robert J Porte
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006-11-30

9.  Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation.

Authors:  Erwin Geuken; Dorien Visser; Folkert Kuipers; Hans Blokzijl; Henri G D Leuvenink; Koert P de Jong; Paul M J G Peeters; Peter L M Jansen; Maarten J H Slooff; Annette S H Gouw; Robert J Porte
Journal:  J Hepatol       Date:  2004-12       Impact factor: 25.083

10.  Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion.

Authors:  Christian Moench; Kerstin Moench; Ansgar W Lohse; Jochen Thies; Gerd Otto
Journal:  Liver Transpl       Date:  2003-03       Impact factor: 5.799

View more
  22 in total

1.  Porcine Isolated Liver Perfusion for the Study of Ischemia Reperfusion Injury: A Systematic Review.

Authors:  Francesca Maione; Nicholas Gilbo; Silvia Lazzaro; Peter Friend; Giovanni Camussi; Renato Romagnoli; Jacques Pirenne; Ina Jochmans; Diethard Monbaliu
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

2.  Ex Situ Normothermic Machine Perfusion of Donor Livers.

Authors:  Negin Karimian; Alix P M Matton; Andrie C Westerkamp; Laura C Burlage; Sanna Op den Dries; Henri G D Leuvenink; Ton Lisman; Korkut Uygun; James F Markmann; Robert J Porte
Journal:  J Vis Exp       Date:  2015-05-26       Impact factor: 1.355

Review 3.  Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease?

Authors:  Davide Ghinolfi; Erion Rreka; Daniele Pezzati; Franco Filipponi; Paolo De Simone
Journal:  Transl Gastroenterol Hepatol       Date:  2017-11-07

4.  Biliary epithelial cells proliferate during oxygenated ex situ liver culture.

Authors:  Congwen Bian; Yiqi Du; Rui Ding; Jun Huang; Yan Dai; Sujin Bao; Lijuan Zhao; Hefang Shen; Jing Dong; Jianjian Xu; Qiru Xiong; Lili Xu
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

5.  Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers.

Authors:  Qiang Liu; Ahmed Nassar; Kevin Farias; Laura Buccini; William Baldwin; Martin Mangino; Ana Bennett; Colin O'Rourke; Toshiro Okamoto; Teresa Diago Uso; John Fung; Kareem Abu-Elmagd; Charles Miller; Cristiano Quintini
Journal:  Liver Transpl       Date:  2014-07-02       Impact factor: 5.799

6.  Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.

Authors:  Simon Bütikofer; Daniela Lenggenhager; Pedro D Wendel Garcia; Ewerton M Maggio; Martina Haberecker; Cäcilia S Reiner; Gregor Brüllmann; Philipp K Buehler; Christoph Gubler; Beat Müllhaupt; Christoph Jüngst; Bernhard Morell
Journal:  Liver Int       Date:  2021-07-04       Impact factor: 8.754

7.  Effect of HSP27 and Cofilin in the injury of hypoxia/reoxygenation on hepatocyte membrane F-actin microfilaments.

Authors:  Yafei Zhang; Jiazhong Wang; Hong Ji; Hongwei Lu; Le Lu; Jinlong Wang; Yiming Li
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Liver Preservation by Aortic Perfusion Alone Compared With Preservation by Aortic Perfusion and Additional Arterial Ex Situ Back-Table Perfusion With Histidine-Tryptophan-Ketoglutarate Solution: A Prospective, Randomized, Controlled, Multicenter Study.

Authors:  Gerd Otto; Michael Heise; Jochen Thies; Michael Pitton; Jens Schneider; Gernot Kaiser; Peter Neuhaus; Otto Kollmar; Michael Barthels; Josef Geks; Wolf Otto Bechstein; Achim Hellinger; Jürgen Klempnauer; Winfried Padberg; Nils Frühauf; Andre Ebbing; Dietmar Mauer; Astrid Schneider; Robert Kwiecien; Kai Kronfeld
Journal:  Transplant Direct       Date:  2017-06-26

9.  Thrombolytic Therapy During ex-vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury.

Authors:  Omar Haque; Siavash Raigani; Ivy Rosales; Cailah Carroll; Taylor M Coe; Sofia Baptista; Heidi Yeh; Korkut Uygun; Francis L Delmonico; James F Markmann
Journal:  Front Surg       Date:  2021-06-17

10.  Hypothermic oxygenated machine perfusion prevents arteriolonecrosis of the peribiliary plexus in pig livers donated after circulatory death.

Authors:  Sanna Op den Dries; Michael E Sutton; Negin Karimian; Marieke T de Boer; Janneke Wiersema-Buist; Annette S H Gouw; Henri G D Leuvenink; Ton Lisman; Robert J Porte
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.